<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01094392</url>
  </required_header>
  <id_info>
    <org_study_id>Hemostasis-NOPHO</org_study_id>
    <nct_id>NCT01094392</nct_id>
  </id_info>
  <brief_title>Hemostasis During Asparaginase Treatment in Acute Lymphoblastic Leukemia(ALL)</brief_title>
  <official_title>Influence on Hemostasis During Prolonged Asparaginase Treatment in Childhood and Adolescent ALL</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aarhus University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Asparaginase is an important drug in the treatment of childhood leukemia. One of the rare but
      severe side effects to the treatment is thrombosis in or outside the central nervous system.

      The aim of this study is to investigate and describe the influence on the coagulation
      parameters during prolonged treatment with asparaginase.

      Hopefully this knowledge will help to foresee the risk of thrombosis and thus making it
      possible to prevent these.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Description of the coagulation parameters</measure>
    <time_frame>December 2016</time_frame>
    <description>The study is a prospective and descriptive study. Levels of coagulation parameters will be analyzed using Two Sample T-Test and the levels of asparaginase in serum will be analyzed by Chi2 test.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Acute Lymphoblastic Leukemia</condition>
  <arm_group>
    <arm_group_label>treatment every 6th week during 6 months</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>treatment every 2nd week during 6 months</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Children and young adults (age 1-17.9 years) newly diagnosed with ALL in the Nordic
        Countries and treated according to the Nordic ALL-protocol NOPHO ALL-2008.

        Written informed consent has been obtained
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Childhood ALL, eligible to receive standard risk or intermediate risk therapy as
             described in the protocol, written informed consent has been obtained

        Exclusion Criteria:

          -  No allergic reactions to PEG-asparaginase
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Birgitte K Albertsen, Ph.D. M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Pediatrics, Skejby Hospital, Aarhus, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Birgitte K Albertsen, M.D.</last_name>
    <phone>+45 89495566</phone>
    <phone_ext>6732</phone_ext>
    <email>biralber@rm.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Aalborg Hospital</name>
      <address>
        <city>Aalborg</city>
        <zip>9000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jon Helgestad, M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Pediatrics, Skejby Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Birgitte K Albertsen, M.D.</last_name>
      <phone>+45 89495566</phone>
      <phone_ext>6732</phone_ext>
      <email>biralber@rm.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Pediatrics, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Birgitte Lausen, M.D.</last_name>
      <phone>+45 35458177</phone>
      <email>Birgitte.Lausen@rh.regionh.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital in Odense</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peder S Wehner, M.D.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 17, 2010</study_first_submitted>
  <study_first_submitted_qc>March 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 29, 2010</study_first_posted>
  <last_update_submitted>March 3, 2016</last_update_submitted>
  <last_update_submitted_qc>March 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aarhus University Hospital</investigator_affiliation>
    <investigator_full_name>Birgitte Klug Albertsen</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>ALL</keyword>
  <keyword>PEG-asparaginase</keyword>
  <keyword>prolonged treatment</keyword>
  <keyword>Thrombosis</keyword>
  <keyword>Central venous line</keyword>
  <keyword>Echocardiography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
    <mesh_term>Leukemia, Lymphoid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatics</mesh_term>
    <mesh_term>Asparaginase</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

